Table 2.
Baseline BCVA (logMAR) | PDT Group I N=100 |
IVB Group II N=104 |
TTT Group III N=222 |
All N=426 |
---|---|---|---|---|
Minimum | 0.15 | 0.22 | 0.10 | 0.10 |
Maximum | 2.00 | 2.00 | 2.00 | 2.00 |
Median | 0.70 | 1.00 | 1.40 | 1.00 |
Mean | 0.62 | 0.82 | 1.10 | 0.85 |
Std. Dev. Confidence interval | 0.31 (0.56–0.68) | 0.52 (0.72–0.92) | 0.45 (1.04–1.16) | 0.51 (0.80–0.90) |
Distribution analysis- test Shapiro-Wilk | W=0.92 p<0.0001 | W=0.83 p<0.0001 | W=0.53 p<0.0001 | W=0.79 p<0.0001 |
Comparison between groups | Kruskal-Wallis Test H=116.06 p<0.0001; Mann-Whitney Test1,2 Z=−5.02 p<0.0001; Mann-Whitney Test1,3 Z=−10.57 p<0.0001; Mann-Whitney Test2,3 Z=4.79 p<0.0001 |
Mann-Whitney Test1,2 comparison between PDT and IVB; Mann-Whitney Test1,3 comparison between PDT and TTT; Mann-Whitney Test2,3 comparison between IVB and TTT.